Skip to main content
    G

    GT Biopharma Inc (GTBP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.54
    -0.18 (-4.97%)

    Market Cap: $7.67M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    GT Biopharma Inc (GTBP) Earnings: Report Dates and Results

    Updated Aug 14, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    GT Biopharma (GTBP) is expected to report earnings on Mar 1, 2027. In the quarter ended Jun 30, 2026, GT Biopharma reported EPS of -$0.12, below the -$0.08 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    59%(13/22)
    Avg Surprise
    -24.12%

    Upcoming Estimates

    Reports Mar 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$2.55
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    GTBP has an expected report date of Mar 1, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, GTBP beat 13 and missed 9. The widest gap in the table came in the quarter ended Mar 31, 2021, when EPS landed 454.55% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Jun 30, 2026-$0.12-$0.08-$0.08 - -$0.08-50.00%MissN/A10 up, 0 downAug 14, 2026
    Mar 31, 2026-$0.11-$0.08-$0.08 - -$0.08-37.50%MissN/A10 up, 0 downMay 15, 2026
    Dec 31, 2025-$121.00-$137.50N/A+12.00%BeatN/A11 up, 0 downMar 2, 2026
    Sep 30, 2025-$0.83-$0.38-$0.38 - -$0.38-118.42%MissN/A11 up, 0 downNov 14, 2025
    Jun 30, 2025-$0.55-$0.68N/A+19.12%BeatN/AN/A0 up, 0 downAug 14, 2025
    Mar 31, 2025-$0.76-$0.64N/A-18.75%MissN/AN/A0 up, 0 downMay 15, 2025
    Dec 31, 2024-$1.66-$1.55N/A-7.10%MissN/AN/AN/AFeb 21, 2025
    Sep 30, 2024-$1.53-$2.70N/A+43.33%BeatN/AN/A0 up, 0 downNov 14, 2024
    Jun 30, 2024-$2.17-$2.70N/A+19.74%BeatN/AN/A0 up, 0 downAug 14, 2024
    Mar 31, 2024-$1.64-$2.70-$2.70 - -$2.70+39.26%BeatN/A10 up, 0 downApr 4, 2024
    Dec 31, 2023-$2.19-$2.70-$2.70 - -$2.70+18.89%BeatN/A10 up, 0 downMar 26, 2024
    Sep 30, 2023-$2.13-$3.30N/A+35.45%BeatN/A10 up, 0 downNov 1, 2023
    Jun 30, 2023-$2.54-$3.60N/A+29.44%BeatN/A20 up, 0 downAug 7, 2023
    Mar 31, 2023-$2.85-$4.35-$4.80 - -$3.90+34.48%BeatN/A20 up, 0 downMay 15, 2023
    Dec 31, 2022-$0.18-$0.17-$0.19 - -$0.16-5.88%MissN/A20 up, 0 downMar 30, 2023
    Sep 30, 2022-$6.61-$3.30-$3.30 - -$3.30-100.30%MissN/A20 up, 0 downOct 31, 2022
    Jun 30, 2022-$2.86-$5.40N/A+47.04%BeatN/AN/A0 up, 0 downAug 11, 2022
    Mar 31, 2022-$0.17-$0.31-$0.47 - -$0.18+45.16%BeatN/A30 up, 0 downMay 16, 2022
    Dec 31, 2021-$15.76-$6.30-$7.21 - -$5.41-150.16%MissN/A30 up, 0 downMar 28, 2022
    Sep 30, 2021-$5.69-$7.05-$9.91 - -$4.20+19.29%BeatN/A3N/ANov 10, 2021
    Jun 30, 2021-$3.92-$7.65N/A+48.76%BeatN/AN/AN/AAug 23, 2021
    Mar 31, 2021-$54.90-$9.90-$9.91 - -$4.80-454.55%MissN/A2N/AApr 16, 2021
    Dec 31, 2020-$3.39-$0.04N/AN/AN/AN/AN/AN/ADec 31, 2020
    Sep 30, 2020-$0.04N/AN/AN/AN/AN/AN/AN/ANov 13, 2020
    Jun 30, 2020-$0.12N/AN/AN/AN/AN/AN/AN/AAug 14, 2020
    Mar 31, 2020-$0.02N/AN/AN/AN/AN/AN/AN/AMay 15, 2020
    Dec 31, 2019-$0.02N/AN/AN/AN/AN/AN/AN/AMar 27, 2020
    Sep 30, 2019-$0.51N/AN/AN/AN/AN/AN/AN/ANov 14, 2019
    Jun 30, 2019-$0.05N/AN/AN/AN/AN/AN/AN/AAug 14, 2019
    Mar 31, 2019-$0.09N/AN/AN/AN/AN/AN/AN/AMay 15, 2019
    Dec 31, 2018-$0.08N/AN/AN/AN/AN/AN/AN/AMar 29, 2019
    Sep 30, 2018-$4.70N/AN/AN/AN/AN/AN/AN/ANov 15, 2018
    Jun 30, 2018-$0.18N/AN/AN/AN/AN/AN/AN/AAug 14, 2018
    Mar 31, 2018-$0.20N/AN/AN/AN/AN/AN/AN/AMay 15, 2018
    Dec 31, 2017-$0.12N/AN/AN/AN/AN/AN/AN/AMar 1, 2018
    Sep 30, 2017-$8.15N/AN/AN/AN/AN/AN/AN/ANov 14, 2017
    Jun 30, 2017-$138.55N/AN/AN/AN/AN/AN/AN/AAug 11, 2017
    Mar 31, 2017-$87.40N/AN/AN/AN/A-585.6%N/AN/AApr 28, 2017
    Dec 31, 2016-$448.21N/AN/AN/AN/A-277.9%N/AN/AMar 31, 2017
    Sep 30, 2016-$29.41N/AN/AN/AN/AN/AN/AN/ANov 14, 2016
    Last 40 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$123.14, after -$7.00 the year before. It was -$499.27 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$123.14N/A
    Dec 31, 2024-$7.00N/A
    Dec 31, 2023-$9.71N/A
    Dec 31, 2022-$9.82N/A
    Dec 31, 2021-$80.27N/A
    Dec 31, 2020-$3.57N/A
    Dec 31, 2019-$0.67N/A
    Dec 31, 2018-$5.16N/A
    Dec 31, 2017-$234.22N/A
    Dec 31, 2016-$499.27N/A

    Frequently Asked Questions About GTBP

    When is GT Biopharma's next earnings date?

    GT Biopharma's next earnings report is expected for Mar 1, 2027.

    Did GTBP beat earnings estimates last quarter?

    No. GT Biopharma reported EPS of -$0.12 for the quarter ended Jun 30, 2026, below the -$0.08 estimate by 50.00%.

    What EPS do analysts expect from GTBP next quarter?

    The consensus EPS estimate for GT Biopharma for the quarter ending Dec 31, 2026 is -$2.55 from 3 analysts.

    How often does GTBP beat earnings estimates?

    GT Biopharma beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -19.66%.